AIDS and Cancer Links
People living with HIV (human immunodeficiency virus) are at greater risk of various forms of cancer. In fact, when these cancers appear, it means the virus has turned into full-blown AIDS (acquired immunodeficiency syndrome).
Greater Access to GIST Rx During FDA Review
Gastrointestinal stromal tumors (GIST) are known as soft tissue sarcomas. They can appear anywhere along the digestive tract. They most commonly start in the stomach. A new drug to treat GIST is headed for review by the U.S. Food and Drug Administration (FDA).
The Big Finish for Sarcoma
Drug research takes years of development, and there comes a day when hard data reveals whether the drug actually works the way it did in the lab.
A Hard Look at Soft Cancers
Sometimes when you go to the doctor, you wonder - how do they keep up with all the recent research and treatment options for all of this stuff? How do they know how chemotherapies stack up against each other?
Head and Neck Cancer Presentation Highlights
A recent presentation at the American Society of Clinical Oncology expanded on several molecular breakthroughs concerning head and neck cancers, and a team of doctors gave an overview of recent conclusions from their respective fields.
Home Run for Pediatric Cancer Drug
An early study looking at a treatment for cancers involving a certain gene mutation had better results than expected, with findings showing that no traces of cancer are detectable in some of the patients in the drug trial.
Fish Show How Cancer Grows
Genetic studies in a laboratory favorite, zebrafish , have shown that a pediatric cancer has more than one type of cell involved. Some cancer cells specialize in metastasis while others are content to stay where they are.
Kidney Drug Works for Other Cancers
Despite being tailor-made for specific targets, some of the newer cancer drugs are useful in other types of cancer. A new kidney cancer drug has shown to be effective in metastatic cancer.
Chemotherapy? Just For The Tumor, Please
Chemotherapy is effective for cancers that have spread out, but that's a double edged sword. You don't want the drugs harming cells in places without cancer, so it would be nice if you could direct it a little.
The Science Behind Sarcomas
Deep tissue cancers, also known as sarcomas, are not as common as carcinomas and consequently less basic research has been resolved on the causes and medical treatments investigated on sarcomas. A series of laboratory molecular experiments resulted in narrowing down more than 2,000 possible targets for pharmaceutical treatment of sarcomas. Scientists conclude that these cancers born from fat or muscle are most likely to share 39 common proteins. Ask your oncologist about clinical trials available to you. Identifying which molecular targets are the most common in sarcomas is ...